Document is current
Any future updates will be listed below
-
Authors
Benavent, Diego https://orcid.org/0000-0001-9119-5330
Carmona, Loreto https://orcid.org/0000-0002-4401-2551
García Llorente, Jose Francisco https://orcid.org/0000-0001-7525-4492
Montoro, María https://orcid.org/0000-0002-1807-7044
Ramirez, Susan https://orcid.org/0000-0002-5538-5126
Otón, Teresa https://orcid.org/0000-0003-3622-7146
Loza, Estíbaliz https://orcid.org/0000-0002-4607-9178
Gómez-Centeno, Antonio https://orcid.org/0000-0002-8674-6692
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 28 February 2025
First Online: 7 April 2025
Declarations
:
: Diego Benavent, Jose Francisco García Llorente, and Antonio Gómez-Centeno were paid consultants to Pfizer for their involvement in developing this manuscript and on the steering committee. Loreto Carmona, Teresa Otón, and Estíbaliz Loza are employees of INMUSC, which Pfizer contracted to conduct and supervise the review. Maria Montoro and Susan Ramirez are Pfizer employees.
